Roche Holding AG

ROG

Company Profile

  • Business description

    Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.

  • Contact

    Grenzacherstrasse 124
    Basel4070
    CHE

    T: +41 616881111

    E: [email protected]

    https://www.roche.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2024

    Employees

    103,605

Roche Holding AG News & Analysis

stocks

3 cheap Wide Moat stocks in a divided industry

All but a couple of shares in this industry have sold off. Our analysts think these three high quality companies have fallen too far. 
stocks

Obesity drug stocks: Where to invest now

Eli Lilly and Novo Nordisk have staged big rallies. Here’s how investors can approach this potentially huge opportunity.
stocks

10 global stocks for a recession

These undervalued stocks come from high-quality companies in defensive sectors.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,697.4064.300.74%
CAC 407,255.0141.690.58%
DAX 4019,322.59176.420.92%
Dow JONES (US)44,296.51426.160.97%
FTSE 1008,262.08112.811.38%
HKSE19,229.97371.14-1.89%
NASDAQ19,003.6531.230.16%
Nikkei 22538,815.88532.031.39%
NZX 50 Index13,112.6870.780.54%
S&P 5005,969.3420.630.35%
S&P/ASX 2008,456.1062.300.74%
SSE Composite Index3,267.19103.21-3.06%

Market Movers